Company Cash Funds: abcellera.com (ABCL)

Graphic logo of AbCellera Bio (ABCL)

The financial stability of AbCellera Biologics (ABCL) is constrained by the volatility of licensing revenues and the success of its partners. The cash balance history on GURU.Markets illustrates current liquidity, where the 0.79 metric reflects capital dynamics. AI algorithms and microfluidics create a technological moat that protects the business. Growth prospects are driven by the implementation of research software and long-term royalties from pharmaceutical behemoths.

Company Cash Funds: AbCellera Biologics Inc. (ABCL) for 07/04/2022 - 11/21/2026

Financial and market metric breakdowns for abcellera.com (ABCL)

- company stock exchange capitalization indicators:
Comprehensive company analysis:AbCellera Biologics Inc ABCL
Signature product of AbCellera Biologics

The AbCellera Biologics (ABCL) business model is based on milestone payments for antibody development, rendering the company independent of macroeconomic cycles. By analyzing changes in cash and cash equivalents, an investor tracks the actual balance of liquid assets and the burn rate, which allows for an assessment of the organization's financial stability and its ability to sustain research until new royalties are received from pharmaceutical partners.

Direct competitors

Company Cash Volume ARGX|BioNTech - Company Cash and Cash Equivalents|Company Cash Volume ABVX (abivax.com)|Company Cash Balance ADMA|Protagonist Therapeutics, Inc. - Company Cash Volume|Company Cash Reserve Immunovant, Inc.|KNSA: Company Cash Volume|GRFS - Company Liquid Assets|ADPT (Adaptive Biotechnologies Inc.) - Company Cash Volume|CLDX: Company Cash Balance|Company Cash Funds Aurinia Pharmaceuticals Inc. (AUPH)|Company Cash Funds BCRX (BioCryst Pharmaceuticals Inc)|Company Cash Volume VERA (Vera Corp)|Company Total Cash Amount DNTH (Dianthus Therapeutics)|PHVS - Company Cash Funds|Company Cash Balance TRML (Tourmaline Bio)|PGEN: Company Cash Volume|Company Cash Reserve Pharming Group N.V. (PHAR)|Company Cash Funds Nektar|upstreambio.com (UPB) - Company Liquid Assets|Company Cash Funds Zenas Bio (ZBIO)|Company Liquid Assets Immunome Inc|Company Cash Funds Gossamer Bio, Inc. GOSS|Company Cash Volume KalVista Pharmaceuticals Inc KALV|SEPN - Company Cash Funds|PVLA - Company Cash Volume|SVRA: Company Cash Volume|RIGL - Company Liquid Assets|ANAB (AnaptysBio Inc) - Company Cash Volume|Company Cash on Hand Astria Corp (ATXS)|Company Cash Volume ENGN|Company Liquid Assets rapt.com|Company Cash Volume JBIO (Aerovate Therapeutics Inc)|Company Liquid Assets Aclaris Therapeutics, Inc. (ACRS)|KYTX - Company Cash Funds|Company Liquid Assets Tiziana Life Sciences TLSA|CABA: Company Cash Volume|Company Cash and Cash Equivalents VTYX|Company Cash on Hand THTX|Company Cash Volume Avalo Therapeutics Inc.|Company Cash Funds Eledon (ELDN)|Company Cash Volume Agenus Inc (AGEN)|Company Cash Volume CLYM (climbbio.com)|ZURA - Company Cash on Hand|atyrpharma.com - Company Cash Volume|ADAG (adagene.com) - Company Cash and Cash Equivalents|IMA (Ikena Oncology) - Company Cash on Hand|Company Cash on Hand Shattuck Labs Inc|EQ (Equillium Inc) - Company Cash Volume|CNTB: Company Cash Balance|Company Cash Volume IMUX|ATRA (Atara Biotherapeutics, Inc.) - Company Cash Balance|Company Cash Volume IFRX (inflarx.de)|X4 Pharmaceuticals - Company Cash Funds|Adicet Bio, Inc. - Company Cash Volume|CELU (celularity.com) - Company Cash and Cash Equivalents|INMB: Company Cash Volume|Barinthus Biotherapeutics PLC (BRNS) - Company Cash Volume|Company Cash Funds Kezar Life Sciences|Company Cash on Hand SAB Biotherapeutics (SABS)|Company Cash Funds Akari Therapeutics Plc (AKTX)|Company Cash on Hand Enlivex Therapeutics, Ltd. ENLV|Q32 Bio Inc. - Company Cash on Hand|GeoVax Labs (GOVX) - Company Cash Reserve|edesabiotech.com - Company Cash Volume|Company Liquid Assets iBio Corp IBIO|CARM: Company Cash Volume|xtlbio.com (XTLB) - Company Cash Volume|BOLT (Bolt Biotherapeutics) - Company Cash Volume|Company Cash on Hand HCW Biologics (HCWB)|Company Cash on Hand APVO (Aptevo Therapeutics)|AIM - Company Cash Reserve|Aditxt - Company Cash on Hand|Company Cash Position gribio.com|XRTX: Company Cash on Hand|Company Cash Balance HIND (Vyome Holdings)|REVB (Revelation Bio) - Company Cash on Hand|Indaptus Corp (INDP) - Company Cash Volume|Company Cash Funds scinai.com|Company Cash on Hand CalciMedica, Inc. (CALI)|Company Cash Funds Affimed NV (AFMD)|Company Cash Funds ALLK (Allakos Inc)|Company Cash Funds HOOKIPA Pharma, Inc. HOOK|Company Liquid Assets IGM Bio (IGMS)|iTeos Pharma - Company Cash Volume|Company Liquid Assets oceanbiomedical.com OCEA|TC BioPharm (TCBP) - Company Cash Funds|Company Cash and Cash Equivalents THRD